D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 60 Citations 14,330 77 World Ranking 1709 National Ranking 848

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Immune system
  • Antibody

His primary areas of study are Epitope, Antigen, T cell, Major histocompatibility complex and CTL*. The various areas that Scott Southwood examines in his Epitope study include Cytotoxic T cell, Peptide sequence and Virology. His work carried out in the field of Peptide sequence brings together such families of science as Peptide binding and Peptide.

His T cell research integrates issues from Molecular biology and Peripheral blood mononuclear cell. Scott Southwood has included themes like Arginine, Citrulline and HLA-DRB1 in his Major histocompatibility complex study. While the research belongs to areas of CTL*, Scott Southwood spends his time largely on the problem of Melanoma, intersecting his research to questions surrounding Adoptive cell transfer.

His most cited work include:

  • The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. (770 citations)
  • Several Common HLA-DR Types Share Largely Overlapping Peptide Binding Repertoires (589 citations)
  • Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. (569 citations)

What are the main themes of his work throughout his whole career to date?

Scott Southwood mostly deals with Epitope, Major histocompatibility complex, Molecular biology, Human leukocyte antigen and Virology. His Epitope research integrates issues from Cytotoxic T cell, CTL* and T cell. His Major histocompatibility complex study incorporates themes from Antigen presentation and Immunogenicity.

His studies deal with areas such as In vitro, MHC restriction, T-cell receptor, MHC class II and Gene as well as Molecular biology. His biological study spans a wide range of topics, including ELISPOT, HLA-A2 Antigen and Degeneracy. His Virology research includes elements of Circumsporozoite protein and Immunodominance.

He most often published in these fields:

  • Epitope (67.27%)
  • Major histocompatibility complex (40.00%)
  • Molecular biology (35.45%)

What were the highlights of his more recent work (between 2004-2013)?

  • Human leukocyte antigen (34.55%)
  • Major histocompatibility complex (40.00%)
  • Epitope (67.27%)

In recent papers he was focusing on the following fields of study:

His main research concerns Human leukocyte antigen, Major histocompatibility complex, Epitope, Virology and Genetics. The various areas that Scott Southwood examines in his Human leukocyte antigen study include ELISPOT, Peripheral blood mononuclear cell and Genotype. His Major histocompatibility complex research incorporates themes from Molecular biology and Peptide.

His Epitope research is multidisciplinary, incorporating perspectives in T cell and Immunogenicity. His work carried out in the field of Virology brings together such families of science as Cellular immunity, Vaccinia and CTL*. In his research on the topic of Immunology, Hepatitis C virus, NS3, NS5A and Hepacivirus is strongly related with Cytotoxic T cell.

Between 2004 and 2013, his most popular works were:

  • Predicting population coverage of T-cell epitope-based diagnostics and vaccines (293 citations)
  • Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire (268 citations)
  • Rationally Engineered Therapeutic Proteins with Reduced Immunogenicity (179 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Immune system
  • Antibody

Scott Southwood mainly focuses on Human leukocyte antigen, Epitope, Major histocompatibility complex, Immunology and Virology. Genetics covers Scott Southwood research in Human leukocyte antigen. His Major histocompatibility complex research is included under the broader classification of Immune system.

He does research in Immunology, focusing on Immunogenicity specifically. His Virology research is multidisciplinary, relying on both Vaccinia, CTL* and Antigen. His Antigen study combines topics in areas such as Peripheral blood mononuclear cell, Viral load and Modified vaccinia Ankara.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.

A. Sette;A. Vitiello;B. Reherman;P. Fowler.
Journal of Immunology (1994)

988 Citations

Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule.

Jonathan A. Hill;Scott Southwood;Alessandro Sette;Anthony M. Jevnikar.
Journal of Immunology (2003)

822 Citations

Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues.

Maria R. Parkhurst;Michael L. Salgaller;Scott Southwood;Paul F. Robbins.
Journal of Immunology (1996)

711 Citations

Several Common HLA-DR Types Share Largely Overlapping Peptide Binding Repertoires

Southwood S;Sidney J;Kondo A;del Guercio Mf.
Journal of Immunology (1998)

707 Citations

Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression.

Y. Kawakami;S. Eliyahu;C. Jennings;K. Sakaguchi.
Journal of Immunology (1995)

689 Citations

Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides

Jeff Alexander;John Sidney;Scott Southwood;Jörg Ruppert.
Immunity (1994)

547 Citations

Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection.

H M Diepolder;J T Gerlach;R Zachoval;R M Hoffmann.
Journal of Virology (1997)

492 Citations

Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1.

Licia Rivoltini;Yutaka Kawakami;Kazuyasu Sakaguchi;Scott Southwood.
Journal of Immunology (1995)

443 Citations

Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus.

Kyong-Mi Chang;Barbara Rehermann;John G. McHutchison;Claudio Pasquinelli.
Journal of Clinical Investigation (1997)

409 Citations

Melanoma-specific CD4 + T Cells Recognize Nonmutated HLA-DR-restricted Tyrosinase Epitopes

Suzanne L. Topalian;Monica I. Gonzales;Maria Parkhurst;Yong F. Li.
Journal of Experimental Medicine (1996)

394 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Scott Southwood

Alessandro Sette

Alessandro Sette

La Jolla Institute For Allergy & Immunology

Publications: 348

John Sidney

John Sidney

La Jolla Institute For Allergy & Immunology

Publications: 215

Bjoern Peters

Bjoern Peters

La Jolla Institute For Allergy & Immunology

Publications: 132

Steven A. Rosenberg

Steven A. Rosenberg

National Institutes of Health

Publications: 97

Anne S. De Groot

Anne S. De Groot

University of Georgia

Publications: 79

Søren Buus

Søren Buus

University of Copenhagen

Publications: 78

Bruce D. Walker

Bruce D. Walker

Harvard University

Publications: 71

Elizabeth J. Phillips

Elizabeth J. Phillips

Vanderbilt University Medical Center

Publications: 65

Simon Mallal

Simon Mallal

Vanderbilt University Medical Center

Publications: 56

Denise L. Doolan

Denise L. Doolan

Australian Institute of Tropical Health and Medicine

Publications: 53

Francesco M. Marincola

Francesco M. Marincola

National Institutes of Health

Publications: 51

Kai W. Wucherpfennig

Kai W. Wucherpfennig

Harvard University

Publications: 50

Pedro Romero

Pedro Romero

University of Lausanne

Publications: 50

Morten Nielsen

Morten Nielsen

Technical University of Denmark

Publications: 48

Stefan Stevanovic

Stefan Stevanovic

University of Tübingen

Publications: 46

Nicholas P. Restifo

Nicholas P. Restifo

National Institutes of Health

Publications: 46

Trending Scientists

Patrick Rives

Patrick Rives

French Institute for Research in Computer Science and Automation - INRIA

Huaxin Lin

Huaxin Lin

University of Oregon

Matthew Andrews

Matthew Andrews

Nokia (United States)

Beno Benhabib

Beno Benhabib

University of Toronto

Toshinobu Higashimura

Toshinobu Higashimura

The University of Shiga Prefecture

Satoshi Takahashi

Satoshi Takahashi

Tohoku University

Hans M. Christen

Hans M. Christen

Oak Ridge National Laboratory

Xiaodong Fang

Xiaodong Fang

Beijing Genomics Institute

Leonard Muscatine

Leonard Muscatine

University of California, Los Angeles

Abdullah Sener

Abdullah Sener

Université Libre de Bruxelles

Yasuhisa Asano

Yasuhisa Asano

Toyama Prefectural University

Maria Paola Canevini

Maria Paola Canevini

University of Milan

Abraham J. Susswein

Abraham J. Susswein

Bar-Ilan University

Ami Klin

Ami Klin

Emory University

David C. Funder

David C. Funder

University of California, Riverside

Richard P. Gallagher

Richard P. Gallagher

University of British Columbia

Something went wrong. Please try again later.